Merck & Co., Inc.
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30250% above fair value
$149.52+3.19 (+2.18%)
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Diluted EPS: $7.28 in FY2025, up 8.0% from a year earlier. That is the highest of the 19 years on record here.
Latest, FY2025
7.28
Period ended Dec 31, 2025
Change on a year earlier
+8.0%
6.74 in FY2024
History
19 years
Since FY2007
Sources
17
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-24) ↗
Reported in Postgres DB financial_values.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Diluted EPS ($) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7.28 | +8.0% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 6.74 | +4,714.3% | Form 10-K (filed 2025-02-25) ↗ |
| FY2023 | Dec 31, 2023 | 0.14 | -97.5% | Form 10-K (filed 2024-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 5.71 | +11.1% | Form 10-K (filed 2023-02-24) ↗ |
| FY2021 | Dec 31, 2021 | 5.14 | +84.9% | Form 10-K (filed 2022-02-25) ↗ |
| FY2020 | Dec 31, 2020 | 2.78 | -27.0% | Form 10-K (filed 2021-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 3.81 | +64.2% | Form 10-K (filed 2020-02-26) ↗ |
| FY2018 | Dec 31, 2018 | 2.32 | +166.7% | Form 10-K (filed 2019-02-27) ↗ |
| FY2017 | Dec 31, 2017 | 0.87 | -38.3% | Form 10-K (filed 2018-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 1.41 | -9.6% | SEC Filing ↗ |
| FY2015 | Dec 31, 2015 | 1.56 | -61.7% | Form 10-K (filed 2016-02-26) ↗ |
| FY2014 | Dec 31, 2014 | 4.07 | +176.9% | Form 10-K (filed 2015-02-27) ↗ |
| FY2013 | Dec 31, 2013 | 1.47 | -26.5% | Form 10-K (filed 2014-02-27) ↗ |
| FY2012 | Dec 31, 2012 | 2 | -1.0% | Form 10-K (filed 2013-02-28) ↗ |
| FY2011 | Dec 31, 2011 | 2.02 | +621.4% | Form 10-K (filed 2012-02-28) ↗ |
| FY2010 | Dec 31, 2010 | 0.28 | -95.0% | Form 10-K (filed 2011-02-28) ↗ |
| FY2009 | Dec 31, 2009 | 5.65 | +55.6% | Form 10-K (filed 2010-03-01) ↗ |
| FY2008 | Dec 31, 2008 | 3.63 | +143.6% | Form 10-K (filed 2010-03-01) ↗ |
| FY2007 | Dec 31, 2007 | 1.49 | – | Form 10-K (filed 2010-03-01) ↗ |
Cite this data
StockData. (2026). Merck Diluted EPS ($), annual FY2007–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db-inc-eps-d
See every metric in the Merck KPI table. Data updated Oct 26, 2026.